Oral Vaccine Market by Type, Application, End-User

List of Tables

The Oral Vaccine Market was valued at USD 16.83 billion in 2023, expected to reach USD 17.91 billion in 2024, and is projected to grow at a CAGR of 6.48%, to USD 26.14 billion by 2030.

The scope of the oral vaccine market encompasses the development, production, and distribution of vaccines administered orally to prevent infectious diseases, particularly in regions where traditional injectable vaccines face logistical challenges. Oral vaccines are crucial due to their ease of administration, which enhances immunization coverage by eliminating the need for needles and trained medical personnel. They are extensively used in immunization programs to combat diarrhea-causing pathogens like rotavirus and cholera, and the technology is being explored for other infections like influenza and COVID-19. The end-use scope primarily includes public health initiatives, healthcare facilities, and travel-related health sectors. Market growth is driven by the increasing prevalence of infectious diseases, need for mass immunization strategies in developing regions, and advancements in oral vaccine technology. Emerging opportunities stem from significant R&D investments, the rising adoption of immunization programs, and the potential integration of messenger RNA (mRNA) technology for developing oral vaccines.

KEY MARKET STATISTICS
Base Year [2023]	USD 16.83 billion
Estimated Year [2024]	USD 17.91 billion
Forecast Year [2030]	USD 26.14 billion
CAGR (%)	6.48%

Additionally, market players should focus on partnerships with governments and non-governmental organizations (NGOs) to enhance distribution in low-income regions. However, challenges such as regulatory hurdles, the stability and efficacy issues of oral formulations, and public skepticism toward oral vaccine effectiveness can impede growth. Limitations in infrastructure and cold chain logistics further pose barriers in rural and underdeveloped areas. To capitalize on market opportunities, companies should prioritize innovation in thermal-stable vaccine formulations, expand research into novel adjuvants to improve efficacy, and reinforce public education campaigns to combat misinformation. Innovations in nanoparticle and microneedle technologies for better oral delivery can significantly enhance market dynamics. As the market nature is highly influenced by health policies and global health initiatives, strategic planning aligned toward collaborative ventures and investment in flexible manufacturing capabilities can ensure adaptability to dynamic market demands, harnessing growth opportunities effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oral Vaccine Market

The Oral Vaccine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Surge in the demand for needle-free vaccines by the pharmaceutical industry
- Growing incidences of infectious diseases
- Increasing production and availability of cost-effective oral vaccines
Market Restraints
- High cost of development and storage of the oral vaccine
Market Opportunities
- Rising development in the oral vaccines products
- Potential of oral vaccines for disease control in wildlife species
Market Challenges
- Side effects associated with the use of oral vaccines

Porter's Five Forces: A Strategic Tool for Navigating the Oral Vaccine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oral Vaccine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oral Vaccine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oral Vaccine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oral Vaccine Market

A detailed market share analysis in the Oral Vaccine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oral Vaccine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oral Vaccine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oral Vaccine Market

A strategic analysis of the Oral Vaccine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oral Vaccine Market, highlighting leading vendors and their innovative profiles. These include Biogen Inc., Bull Bio - NCIPD Ltd., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Janssen Global Services, LLC, Lumen Bioscience, Inc., Novo Nordisk A/S, Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Shanghai BravoBio Co., Ltd., Takeda Pharmaceutical Company Limited, Valneva SE, Vaxart, Inc., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Oral Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Type, market is studied across Attenuated and Inactive.
Based on Application, market is studied across Cholera, Polio, Rabies, Respiratory Infection, and Tuberculosis.
Based on End-User, market is studied across Clinics and Hospitals.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-035DA3C63714

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Surge in the demand for needle-free vaccines by the pharmaceutical industry
  - 5.1.1.2. Growing incidences of infectious diseases
  - 5.1.1.3. Increasing production and availability of cost-effective oral vaccines
- 5.1.2. Restraints
  - 5.1.2.1. High cost of development and storage of the oral vaccine
- 5.1.3. Opportunities
  - 5.1.3.1. Rising development in the oral vaccines products
  - 5.1.3.2. Potential of oral vaccines for disease control in wildlife species
- 5.1.4. Challenges
  - 5.1.4.1. Side effects associated with the use of oral vaccines
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Oral Vaccine Market, by Type

6.1. Introduction
6.2. Attenuated
6.3. Inactive

7. Oral Vaccine Market, by Application

7.1. Introduction
7.2. Cholera
7.3. Polio
7.4. Rabies
7.5. Respiratory Infection
7.6. Tuberculosis

8. Oral Vaccine Market, by End-User

8.1. Introduction
8.2. Clinics
8.3. Hospitals

9. Americas Oral Vaccine Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Oral Vaccine Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Oral Vaccine Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Biogen Inc.
2. Bull Bio - NCIPD Ltd.
3. F. Hoffmann-La Roche Ltd.
4. GlaxoSmithKline PLC
5. Janssen Global Services, LLC
6. Lumen Bioscience, Inc.
7. Novo Nordisk A/S
8. Pfizer Inc.
9. Sanofi S.A.
10. Serum Institute of India Pvt. Ltd.
11. Shanghai BravoBio Co., Ltd.
12. Takeda Pharmaceutical Company Limited
13. Valneva SE
14. Vaxart, Inc.
15. Zoetis Inc.